Summary of clinicopathological factors and mucin expression in the non-recurrence group (n = 40)
| Age (years) | Sex | Site | Size (cm)* | Margin† | Capsular invasion | Tumour variant‡ | Mucin expression | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MUC1 | MUC2 | MUC4 | MUC5AC | MUC6 | |||||||||||
| CORE | DF3 | MY.IE12 | GP | HMFG-1 | |||||||||||
| *Maximum diameter; †+, incomplete surgical resection; −, complete surgical resection microscopically; ‡A, stroma rich variant; B, intermediate, C, stroma poor variant. | |||||||||||||||
| The positively stained neoplastic cells were graded as follows: −, less than 5% of neoplastic cells stained; +, more than 5% but less than 30% of neoplastic cells stained; ++, more than 30% of neoplastic cells stained. | |||||||||||||||
| GP, glycoprotein; SM, submandibular. | |||||||||||||||
| 49.4 (14.7) | 6 M, 34 F | 17 parotid, 7 SM, 13 palate, 3 other oral mucosa | 2.3 (1.2) | 26 + | 24 + | 14 A | 25 − | 25 − | 18 − | 18 − | 33 − | 38 − | 35 − | 36 − | 26 − |
| 12 − | 16 − | 17 B | 10 + | 12 + | 16 + | 16 + | 7 + | 2 + | 5 + | 4 + | 10 + | ||||
| 9 C | 5 ++ | 3 ++ | 6 ++ | 6 ++ | 0 ++ | 0 ++ | 0 ++ | 0 ++ | 4 ++ | ||||||